Schenkein David P
- SEC CIK
- 0001578200
No open-market purchases or sales filed in the past year.
Current role at each company
- PRME Prime Medicine, Inc.Directoras of Jun 8, 2026
- DNLI Denali Therapeutics Inc.Directoras of Jun 5, 2026
- REGN Regeneron Pharmaceuticals, Inc.Directoras of Jan 6, 2026
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 24, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schenkein David P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNLI Denali Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 (view filing) | Nov 11 | 2 days | Schenkein David PDirector | SSale | −59.4K | $32.51 | −$1.93M | −86.6%9.22K after | 2 lots10b5-1 |
AGIO Agios Pharmaceuticals, Inc.
Director9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Schenkein David PDirector | SSale | −69.3K | $34.67 | −$2.40M | −36.1%122.9K after | 2 lots |
| Feb 27, 2024 (view filing) | Feb 23-26 | 4 days | Schenkein David PDirector | SSale | −68.1K | $33.09 | −$2.25M | −35.7%122.9K after | 2 lots |
| Apr 5, 2023 (view filing) | Apr 3 | 2 days | Schenkein David PDirector | SSale | −16.4K | $22.85 | −$373.9K | −12.2%117.9K after | 10b5-1 |
| Mar 29, 2023 (view filing) | Mar 27 | 2 days | Schenkein David PDirector | SSale | −20.0K | $22.15 | −$443.0K | −14.5%117.9K after | 10b5-1 |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Schenkein David PDirector | SSale | −20.0K | $22.49 | −$449.8K | −14.5%117.9K after | 2 lots |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Schenkein David PDirector | SSale | −20.0K | $25.37 | −$507.4K | −14.5%117.9K after | |
| Feb 15, 2023 (view filing) | Feb 13 | 2 days | Schenkein David PDirector | SSale | −20.0K | $28.62 | −$572.4K | −14.5%117.9K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Schenkein David PDirector | SSale | −20.0K | $29.33 | −$586.6K | −14.5%117.9K after | 2 lots |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Schenkein David PDirector | SSale | −20.0K | $28.85 | −$577.1K | −14.5%117.9K after | 2 lots |